Kimberly-Clark offers bonds to help fund Tylenol maker takeover


Kenvue has struggled financially since being spun off from Johnson & Johnson in 2023, and the company found itself battling with the Trump administration last year over the safety of its biggest product, Tylenol. Its portfolio also includes Neutrogena lotion, Listerine mouthwash, Benadryl allergy medicine and Band-Aid wound care products.



Source link

  • Related Posts

    Save-On-Foods loyalty program members had personal information accessed in cybersecurity breach

    Listen to this article Estimated 3 minutes The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Apple Sends Invites Out for ‘Pro and Tell’ Special Event on Oct. 28

    Apple Sends Invites Out for ‘Pro and Tell’ Special Event on Oct. 28

    Trump signs executive order creating women’s health division within NIH

    Trump signs executive order creating women’s health division within NIH

    Hideo Kojima Says Whalefall Movie Ruined Eating Squid for Him

    Hideo Kojima Says Whalefall Movie Ruined Eating Squid for Him

    Delta Air Lines Just Ordered 30 Boeing 787-10s, But Won’t Receive A Single One Until 2031

    Delta Air Lines Just Ordered 30 Boeing 787-10s, But Won’t Receive A Single One Until 2031

    Oregon WR Evan Stewart arrested on DUI charge

    Oregon WR Evan Stewart arrested on DUI charge

    Rob Shaw: Municipal election delivers a wake-up call for the NDP

    Rob Shaw: Municipal election delivers a wake-up call for the NDP